Medibio Limited (ASX: MEB)

Company Profile– Founded in 1988, Medibio Limited (ASX: MEB) is involved in the operations of developing diagnostic systems for mental health illness in Australia and the United States. Mr. Brian Mower is the CFO and the interim CEO of the company. The company is currently headed in 100 Albert Road Level 4 South Melbourne, Australia.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report